ArticleBlood advances2022
Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma.
Tycel Phillips et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papertrialcites it
ArticleBlood advances2022
Tycel Phillips et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.